Table 5.
Unadjusted and adjusted logistic regression analysis for outcome PPH secondary to uterine atony
| Predictor | Denom/Numerator of OR |
Unadjusted OR (95% CI) p-value |
Adjusted OR (95% CI) p-value |
|---|---|---|---|
| Oxytocin AUC | 5000 mU increase | 1.47 (1.17, 1.93) <0.001 |
1.58 (1.05, 2.57) 0.026 |
| Race | Hispanic/Caucasian | 5.25 (1.69, 16.39) 0.005 |
1.36 (0.41, 5.59) 0.540 |
| BMI | 1-unit increase | 0.94 (0.88, 1.01) 0.11 |
0.97 (0.89, 1.04) 0.449 |
| Admission Hematocrit | 1-unit increase | 0.86 (0.77, 0.95) 0.004 |
0.05 (0.002, 0.93) 0.044 |
| Induction status | Yes/No | 2.17 (0.95, 5.06) 0.063 |
1.16 (0.34, 3.78) 0.803 |
| Preeclampsia | Yes/No | 4.90 (1.66, 14.43) <0.001 |
* |
| Magnesium therapy | Yes/No | 3.43 (1.14, 10.34) <0.001 |
1.17 (0.27, 5.34) 0.832 |
| Chorioamnionitis | Yes/No | 2.10 (0.93, 10.50) 0.30 |
4.38 (0.42, 58.5) 0.217 |
Not included in adjusted analysis since preeclampsia and magnesium therapy are dependent on each other